These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1964200)

  • 1. Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities.
    Laminski NA; Meyers AM; Sonnekus MI; Smyth AE
    Nephron; 1990; 56(4):379-86. PubMed ID: 1964200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.
    Akinci M; Esen T; Koçak T; Ozsoy C; Tellaloğlu S
    Eur Urol; 1991; 19(3):240-3. PubMed ID: 1649759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical studies in paraplegic renal stone patients. 2. Urinary excretion of citrate, inorganic pyrophosphate, silicate and urate.
    Burr RG; Nuseibeh I; Abiaka CD
    Br J Urol; 1985 Jun; 57(3):275-8. PubMed ID: 2988686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
    Hofbauer J; Höbarth K; Zechner O
    Z Urol Nephrol; 1990 Nov; 83(11):597-602. PubMed ID: 2100085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C; Németh J; Büki B; Vargha P
    Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.
    Cupisti A; Morelli E; Lupetti S; Meola M; Barsotti G
    Nephron; 1992; 61(1):73-6. PubMed ID: 1528345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary citrate excretion in patients with renal calculi.
    Menon M; Mahle CJ
    J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary citrate in kidney stone disease.
    Usui Y; Matsuzaki S; Matsushita K; Shima M
    Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of recurrent stone formers with special reference to renal tubular acidosis.
    Singh PP; Pendse AK; Ahmed A; Ramavataram DV; Rajpurohit SK
    Urol Res; 1995; 23(3):201-3. PubMed ID: 7483148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.
    Okamoto N; Aruga S; Matsuzaki S; Takahashi S; Matsushita K; Kitamura T
    Int J Urol; 2007 Apr; 14(4):344-9. PubMed ID: 17470169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.